MORRISVILLE, N.C.--(BUSINESS WIRE)--TearScience, Inc., a privately-held medical device company, announced that the Toronto-based Herzig Eye Institute, one of the leading authorities in laser vision correction and advanced cataract and refractive surgery, is the first eye care centre in North America to introduce the innovative LipiFlow® evaporative dry eye disease treatment system, which has received a medical device license from Health Canada.
